(Q38968588)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27687982%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

review article

1 reference

title

Epstein-Barr virus: more than 50 years old and still providing surprises (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27687982%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27687982%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

author name string

Lee Fah Yap

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27687982%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Paul G Murray

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27687982%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

language of work or name

English

0 references

publication date

30 September 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27687982%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

published in

Nature Reviews Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27687982%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27687982%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27687982%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

page(s)

789-802

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27687982%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrc.2016.92

24 March 2020

exact match

0 references

cites work

Global burden of cancers attributable to infections in 2008: a review and synthetic analysis

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

The role of Epstein-Barr virus in epithelial malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Herpes-Type Virus and Chromosome Marker in Normal Leukocytes after Growth with Irradiated Burkitt Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Establishment of cell lines from peripheral leucocytes in infectious mononucleosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Efficiency of transformation of lymphocytes by Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

The curious case of the tumour virus: 50 years of Burkitt's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

The genome of Epstein-Barr virus type 2 strain AG876.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Genomic sequencing and comparative analysis of Epstein-Barr virus genome isolated from primary nasopharyngeal carcinoma biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Whole-genome sequencing of the Akata and Mutu Epstein-Barr virus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Identification and characterization of EBV genomes in spontaneously immortalized human peripheral blood B lymphocytes by NGS technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1,000 Genomes Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus gene expression in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Persisting oncogenic herpesvirus induced by the tumour promoter TPA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Efficient replication of Epstein-Barr virus in stratified epithelium in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

T-cell control of Epstein–Barr virus-infected B cells is lost during P. falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

PD-1 dependent exhaustion of CD8+ T cells drives chronic malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

A comparison of Epstein-Barr virus-specific T-cell immunity in malaria-endemic and -nonendemic regions of Papua New Guinea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

The effects of acute malaria on Epstein-Barr virus (EBV) load and EBV-specific T cell immunity in Gambian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

A multifactorial role for P. falciparum malaria in endemic Burkitt's lymphoma pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

AID expression in peripheral blood of children living in a malaria holoendemic region is associated with changes in B cell subsets and Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Activation of the Epstein-Barr virus lytic cycle by the latex of the plant Euphorbia tirucalli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Marker band in one chromosome 14 from Burkitt lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Transcriptional activation of the translocated c-myc oncogene in burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Functional role for c-myc in mitogenic response to platelet-derived growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Close link between reduction of c-myc expression by interferon and, G0/G1 arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Induction of apoptosis in fibroblasts by c-myc protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus provides a survival factor to Burkitt's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Antagonistic effects of c-myc and Epstein-Barr virus latent genes on the phenotype of human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Infectious mononucleosis. Epstein-Barr-virus shedding in saliva and the oropharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

EBV persistence in memory B cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Persistence of the Epstein-Barr virus and the origins of associated lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus: exploiting the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus: a paradigm for persistent infection - for real and in virtual reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

The intersection of Epstein-Barr virus with the germinal center

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Germinal center B cells latently infected with Epstein-Barr virus proliferate extensively but do not increase in number

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Thymic origin of atypical lymphoid cells in infectious mononucleosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Atypical lymphocytes in acute infectious mononucleosis. Identification by multiple T and B lymphocyte markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Long-term T-cell-mediated immunity to epstein-barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Long-term T-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Reticulum Cell Sarcoma after Renal Homotransplantation and Azathioprine and Prednisone Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Cyclosporin A immunosuppression, Epstein-Barr antibody, and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Cure of Dysgerminoma with Widespread Metastases Appearing after Renal Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

X-linked recessive progressive combined variable immunodeficiency (Duncan's disease)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

X-linked lymphoproliferative disease: twenty-five years after the discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Hodgkin's disease in patients with previous infectious mononucleosis: 30 years' experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Lymphadenopathy morphologically consistent with Hodgkin's disease associated with Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus infection in vitro can rescue germinal center B cells with inactivated immunoglobulin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Molecular mimicry of the antigen receptor signalling motif by transmembrane proteins of the Epstein-Barr virus and the bovine leukaemia virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Outbreak of Burkitt's-like lymphoma in homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Insights into B cells and HIV-specific B-cell responses in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Optimal treatment for chronic active Epstein-Barr virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Nasopharyngeal carcinoma: Significance of changes in epstein-barr virus-related antibody patterns following therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Non-viral environmental risk factors for nasopharyngeal carcinoma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus: 40 years on

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

The genomic landscape of nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with epstein-barr virus-negative carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Different pattern of allelic loss in Epstein-Barr virus-positive gastric cancer with emphasis on the p53 tumor suppressor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Comprehensive molecular characterization of gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus in gastric carcinomas and gastric stump carcinomas: a late event in gastric carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Association of a distinctive strain of Epstein-Barr virus with gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Smooth muscle tumors of soft tissue and non-uterine viscera: biology and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cell-mediated transfer infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

In-cell infection: a novel pathway for Epstein-Barr virus infection mediated by cell-in-cell structures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Highly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Pyothorax-associated lymphoma: a review of 106 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Cytolytic virus activation therapy for Epstein-Barr virus-driven tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Efficacy of targeted FasL in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Small molecule inhibition of Epstein-Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Computational analysis of EBNA1 "druggability" suggests novel insights for Epstein-Barr virus inhibitor design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Effective treatment of metastatic forms of Epstein-Barr virus-associated nasopharyngeal carcinoma with a novel adenovirus-based adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Herpesvirus latency confers symbiotic protection from bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Geographical prevalence of two types of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Cell growth effects of Epstein-Barr virus leader protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Identification of virus-encoded microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

miRBase: annotating high confidence microRNAs using deep sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

The role of miRNAs and EBV BARTs in NPC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus maintains lymphomas via its miRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

EBV BART MicroRNAs Target Multiple Pro-apoptotic Cellular Genes to Promote Epithelial Cell Survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

The Epstein-Barr virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Clustered microRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

The members of an Epstein-Barr virus microRNA cluster cooperate to transform B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Role of EBER and BARF1 in nasopharyngeal carcinoma (NPC) tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus BGLF4 kinase retards cellular S-phase progression and induces chromosomal abnormality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Quantitative and qualitative RNA-Seq-based evaluation of Epstein-Barr virus transcription in type I latency Burkitt's lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus and oncogenesis: from latent genes to tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Genetic and epigenetic changes in nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Analysis of bcl-2 expression in normal, inflamed, dysplastic nasopharyngeal epithelia, and nasopharyngeal carcinoma: association with p53 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Telomerase activity is frequently found in metaplastic and malignant human nasopharyngeal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Lymphomas occurring late after solid-organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Infectious Mononucleosis, Childhood Social Environment, and Risk of Hodgkin Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein-Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Epidemiologic patterns of Hodgkin's Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Burkitt's lymphoma in a homosexual

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Evaluation of E-cadherin, β-catenin and vimentin protein expression using quantitative immunohistochemistry in nasopharyngeal carcinoma patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.92

Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells

31 March 2020

1 reference

12 December 2020

Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV

1 reference

12 December 2020

Identification of transcribed regions of Epstein-Barr virus DNA in Burkitt lymphoma-derived cells

1 reference

12 December 2020

Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7.

1 reference

12 December 2020

Immunofluorescence in cells derived from Burkitt's lymphoma.

1 reference

12 December 2020

A transforming function of the BARF1 gene encoded by Epstein-Barr virus

1 reference

12 December 2020

Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma

1 reference

12 December 2020

Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells

1 reference

12 December 2020

A cohort study of cancer following infectious mononucleosis.

1 reference

12 December 2020

Specific translocations characterize Burkitt's-like lymphoma of homosexual men with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice

1 reference

12 December 2020

Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes

1 reference

12 December 2020

Burkitt lymphoma in New Guinea: establishment of a line of lymphoblasts in vitro and description of their fine structure

1 reference

12 December 2020

Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma.

1 reference

12 December 2020

Malignant lymphomas in transplantation patients

1 reference

12 December 2020

Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes

1 reference

12 December 2020

Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye

1 reference

12 December 2020

Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma

1 reference

12 December 2020

EB viral genomes in epithelial nasopharyngeal carcinoma cells

1 reference

12 December 2020

Non-human Primate Lymphocryptoviruses: Past, Present, and Future

1 reference

12 December 2020

Indirect immunofluorescence tests with sera from African children and cultured Burkitt lymphoma cells

1 reference

12 December 2020

Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata

1 reference

12 December 2020

Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts

1 reference

12 December 2020

Epstein-Barr virus-associated antibody patterns in carcinoma of the post-nasal space

1 reference

12 December 2020

Analysis of major histocompatibility complex class I, TAP expression, and LMP2 epitope sequence in Epstein-Barr virus-positive Hodgkin's disease.

1 reference

12 December 2020

The Epstein-Barr virus lytic transactivator Zta interacts with the helicase-primase replication proteins.

1 reference

12 December 2020

Altered expression of two Epstein-Barr virus early genes localized in BamHI-A in nonproducer Raji cells

1 reference

12 December 2020

Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization

1 reference

12 December 2020

Expression and tumorigenicity of the Epstein-Barr virus BARF1 gene in human Louckes B-lymphocyte cell line.

1 reference

12 December 2020

Epstein-Barr viral DNA in tissues of Hodgkin's disease

1 reference

12 December 2020

Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.

1 reference

12 December 2020

Clonal transformation of adult human leukocytes by Epstein-Barr virus

1 reference

12 December 2020

Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups.

1 reference

12 December 2020

Epstein-Barr virus-associated gastric adenocarcinoma

1 reference

12 December 2020

Oncogenic induction of cellular high CpG methylation by Epstein-Barr virus in malignant epithelial cells

1 reference

12 December 2020

Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication

1 reference

12 December 2020

The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders. Clinical, pathologic, and virologic correlation

1 reference

12 December 2020

Lymphomas occurring late after solid-organ transplantation: influence of treatment on the clinical outcome

1 reference

12 December 2020

Apoptosis in Burkitt lymphoma cells is driven by c-myc.

1 reference

12 December 2020

A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1.

1 reference

12 December 2020

A monoclonal immunoblastic sarcoma in donor cells bearing Epstein-Barr virus genomes following allogeneic marrow grafting for acute lymphoblastic leukemia

1 reference

12 December 2020

Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells.

1 reference

12 December 2020

trans-acting requirements for replication of Epstein-Barr virus ori-Lyt

1 reference

12 December 2020

Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups

1 reference

12 December 2020

Functional replacement of the intracellular region of the Notch1 receptor by Epstein-Barr virus nuclear antigen 2.

1 reference

12 December 2020

[Translocations t(2;8) and t(8;22) in continuous cell lines of African Burkitt's lymphoma]

1 reference

12 December 2020

Epidemiology of Hodgkin's disease

1 reference

12 December 2020

Epstein-Barr virus latent and replicative gene expression in post-transplant lymphoproliferative disorders and AIDS-related non-Hodgkin's lymphomas. French Study Group of Pathology for HIV-associated Tumors

1 reference

12 December 2020

Undifferentiated carcinoma of the major salivary glands

1 reference

12 December 2020

Immunochemical Characterization of Epstein-Barr Virus-Associated Early and Late Antigens in n -Butyrate-Treated P3HR-1 Cells

1 reference

12 December 2020